Cardiovascular Systems Inc Quick Ratio (CSII) starting from the second quarter 2022 to second quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Cardiovascular Systems Inc   (NASDAQ: CSII)

Cardiovascular Systems Inc 's Quick Ratio

CSII's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2022, Quick Ratio deteriorated to 3.59 above company average Quick Ratio.

Within Medical Equipment & Supplies industry 67 other companies have achieved higher Quick Ratio than Cardiovascular Systems Inc in second quarter 2022. While Quick Ratio total ranking in the second quarter 2022 has deteriorated compared to the prior quarter from 1002 to 1045.

Explain Quick Ratio?
How much Cash & cash equivalents CSII´s has?
What are CSII´s Current Liabilities?




CSII Quick Ratio (Dec 31 2022)
Q2
(Sep 30 2022)
Q1
(Jun 30 2022)
Q4
(Mar 31 2022)
Q3
(Dec 31 2021)
Q2
Y / Y Current Liabilities Change -12.22 % -13.67 % -26.89 % -7.98 % -12.9 %
Y / Y Cash & cash equivalent Change -25.23 % -23.38 % -22.8 % -18.49 % -21.56 %
Quick Ratio MRQ 3.59 3.87 4 3.71 4.22
CSII's Total Ranking # 1045 # 1002 # 230 # 959 # 31
Seq. Current Liabilities Change -1.06 % -7.01 % -13.93 % 10.84 % -2.69 %
Seq. Cash & cash equivalent Change -8.17 % -10.06 % -7.1 % -2.54 % -5.9 %



Quick Ratio second quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 68
Healthcare Sector # 526
Overall Market # 1045


Quick Ratio Statistics
High Average Low
5.95 3.31 1.73
(Dec 31 2013)   (Jun 30 2016)




Financial Statements
Cardiovascular Systems Inc 's Current Liabilities $ 37 Millions Visit CSII's Balance sheet
Cardiovascular Systems Inc 's Cash & cash equivalent $ 132 Millions Visit CSII's Balance sheet
Source of CSII's Sales Visit CSII's Sales by Geography


Cumulative Cardiovascular Systems Inc 's Quick Ratio

CSII's Quick Ratio for the trailling 12 Months

CSII Quick Ratio

(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
(Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth -15.64 % -15.7 % -13.87 % 17.9 % 20.75 %
Y / Y Cash & cash equivalent TTM Growth -22.32 % -21.5 % -19.63 % -16.6 % -0.65 %
Quick Ratio TTM 3.79 3.94 4.06 4 4.12
Total Ranking TTM # 4910 # 191 # 892 # 4492 # 4466
Seq. Current Liabilities TTM Growth -3.09 % -3.43 % -7.9 % -2.12 % -3.16 %
Seq. Cash & cash equivalent TTM Growth -6.83 % -6.3 % -6.35 % -4.99 % -5.84 %


On the trailing twelve months basis In spite of the year on year decrease in CSII's Current Liabilities to $36.76 millions, cumulative Quick Ratio to 3.79 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 258 other companies have achieved higher Quick Ratio than Cardiovascular Systems Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2022 from 191 to 4910.

Explain Quick Ratio?
How much Cash & cash equivalents CSII´s has?
What are CSII´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 259
Healthcare Sector # 1219
Within the Market # 4910


trailing twelve months Quick Ratio Statistics
High Average Low
4.63 2.48 1.39
(Sep 30 2014)   (Mar 31 2020)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Medical Equipment & Supplies Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Innovative Eyewear Inc   9.78 $ 3.591  Millions$ 0.367  Millions
Aethlon Medical Inc   9.36 $ 17.072  Millions$ 1.824  Millions
Silk Road Medical Inc   8.73 $ 213.674  Millions$ 24.488  Millions
Skinhealth Systems Inc   8.57 $ 568.197  Millions$ 66.289  Millions
Outset Medical Inc   8.52 $ 442.651  Millions$ 51.949  Millions
Transmedics Group Inc   8.50 $ 201.182  Millions$ 23.661  Millions
Inspira Technologies Oxy B H N Ltd  8.26 $ 27.842  Millions$ 3.372  Millions
Neuropace Inc   8.10 $ 77.409  Millions$ 9.561  Millions
Inmode Ltd   7.97 $ 557.114  Millions$ 69.943  Millions
Medinotec Inc   7.96 $ 2.847  Millions$ 0.358  Millions
Invivo Therapeutics Holdings Corp   7.89 $ 16.351  Millions$ 2.072  Millions
Nexgel Inc   7.69 $ 6.609  Millions$ 0.859  Millions
Beyond Air Inc   7.49 $ 80.242  Millions$ 10.712  Millions
Avita Medical Inc   7.42 $ 79.367  Millions$ 10.693  Millions
Monogram technologies inc   7.42 $ 10.469  Millions$ 1.412  Millions
Solana Company  7.32 $ 14.549  Millions$ 1.988  Millions
Meihua International Medical Technologies Co Ltd  6.80 $ 53.473  Millions$ 7.862  Millions
Iradimed Corporation  6.78 $ 57.961  Millions$ 8.554  Millions
Asensus Surgical Inc   6.77 $ 70.524  Millions$ 10.414  Millions
Alpha Pro Tech Ltd   6.77 $ 16.290  Millions$ 2.406  Millions
Lyra Therapeutics Inc   6.77 $ 97.894  Millions$ 14.470  Millions
Vivani Medical Inc   6.61 $ 45.076  Millions$ 6.822  Millions
Privia Health Group Inc   6.59 $ 347.992  Millions$ 52.837  Millions
Cutera Inc   6.50 $ 317.314  Millions$ 48.831  Millions
Retractable Technologies Inc  6.37 $ 49.379  Millions$ 7.752  Millions
Bluejay Diagnostics Inc  6.17 $ 10.115  Millions$ 1.640  Millions
Procept Biorobotics Corporation  5.84 $ 221.859  Millions$ 37.990  Millions
Inari Medical Inc   5.81 $ 326.401  Millions$ 56.174  Millions
Penumbra Inc  5.61 $ 309.702  Millions$ 55.239  Millions
Clearpoint Neuro Inc   5.52 $ 37.489  Millions$ 6.788  Millions

Date modified: 2026-09-08T15:10:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.